Humacyte is going public via a SPAC merger that infuses it with $255 million for its regenerative medicine pipeline. The biotech's technology produces universally implantable tissue that functions like human blood vessels.
Eli Lilly is paying $125 million up front to team up with Rigel Pharmaceuticals on drugs that block a signaling protein involved in inflammation. With the alliance, Lilly joins Sanofi and Denali Therapeutics in the pursuit of drugs that block this protein.
Covid 19 coronavirus: The Baker twins - disease expert s TV interviews confuse patients at Sydney clinic
18 Feb, 2021 07:24 AM
3 minutes to read
David and Michael Baker. Photo / Supplied
He s known as one of the public faces of the Covid-19 pandemic in New Zealand, but Michael Baker s regular appearances on TV are causing confusion across the ditch.
People in Sydney are confusing the University of Otago epidemiologist with his identical twin brother, David, a GP in central Sydney.
Dr David Baker s patients keep asking him why he s always appearing on New Zealand television to talk about Covid-19, not realising the brothers are twins.
Data breach: Reserve Bank likely facing $250K ransom; files from other victims made public
18 Feb, 2021 01:45 AM
6 minutes to read
A US law firm and a Singapore telco caught up in the same data breach as the Reserve Bank have had stolen files leaked online by a ransomware gang. A security expert says that means it s now possible that some of the RBNZ s stolen files - described by the banks as sensitive - could now also be leaked on to the internet in a bid to pressure the NZ central bank into paying a ransom.
Read More
In mid-December, Accellion FTA - a service for sharing large files - suffered a data breach. The Reserve bank, top US law firm Jones Day and Singapore s largest phone company, Singtel and some 47 others, including the Australian Securities and Investments Commission, had data stolen in the cyberheist.